Status:
COMPLETED
A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines
Lead Sponsor:
AbbVie
Conditions:
Upper Facial Lines
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Facial lines that develop from repeated facial expression, such as glabellar lines (GL), lateral canthal lines (LCL), and forehead lines (FHL), are typically treated by selectively weakening specific ...
Eligibility Criteria
Inclusion
- Moderate to severe Glabellar Lines, Lateral Canthal Lines, and Forehead Lines.
- Sufficient visual acuity without the use of eyeglasses (contact lens use acceptable) to accurately assess their facial wrinkles.
Exclusion
- Presence or history of any medical condition that may place the participant at increased risk to BOTOX Cosmetic or interfere with the study evaluation.
- Presence of tattoos, jewelry, or clothing which obscures or interferes with the target area of interest and cannot be removed.
- History of known immunization or hypersensitivity to any botulinum toxin serotype.
Key Trial Info
Start Date :
February 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 17 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06218251
Start Date
February 5 2024
End Date
December 17 2024
Last Update
November 24 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Skin Wellness Dermatology - Homewood /ID# 248469
Birmingham, Alabama, United States, 35209-8314
2
The Research Center at The Maas Clinic /ID# 256633
San Francisco, California, United States, 94115-1809
3
Pacific Clinical Innovations /ID# 248467
Vista, California, United States, 92083-6030
4
Kavali Plastic Surgery and Skin Renewal Center /ID# 248472
Atlanta, Georgia, United States, 30328